Q-Line Biotech Limited IPO

Established in 2010, Q-Line Biotech Limited is engaged in the development, manufacturing, and marketing of a diverse range of diagnostic reagents, including kits and point-of-care (POC) devices, alongside medical consumables. In addition to manufacturing, the company also imports, supplies, and distributes various diagnostic equipment to meet distinct healthcare testing requirements.

Don't have a Navia account? Sign up

Since 2013, the company has been supplying these diagnostic equipment and In-Vitro Diagnostic (IVD) products to the healthcare sector. These specialized medical solutions are delivered either directly or through a network of distributors, serving primarily diagnostic service providers, hospitals, and medical colleges.

How do I apply for the Q-Line Biotech IPO?

You can apply for the Q-Line Biotech IPO using any supported UPI app by following two steps:

• Enter your bid on Navia App
• Accept UPI mandate on your phone

On acceptance of the mandate, the bid amount will get blocked in your bank account.